360 High-Risk Vulnerability Immunization Tool V2.0 vs AhnLab Endpoint PLUS: Side-by-Side Comparison (2026)

360 High-Risk Vulnerability Immunization Tool V2.0: Tool that immunizes Windows systems against critical vulnerabilities. built by 360 Security Group (Qihoo 360). Core capabilities include Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation..

AhnLab Endpoint PLUS: Comprehensive endpoint security platform with EPP, EDR, and sandbox capabilities. built by AhnLab. Core capabilities include Anti-malware protection, Endpoint Protection Platform (EPP), Endpoint Detection and Response (EDR)..

Both serve the Endpoint Protection Platform market but differ in approach, feature depth, and target audience.

360 High-Risk Vulnerability Immunization Tool V2.0 differentiates with Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation. AhnLab Endpoint PLUS differentiates with Anti-malware protection, Endpoint Protection Platform (EPP), Endpoint Detection and Response (EDR).

360 High-Risk Vulnerability Immunization Tool V2.0 is developed by 360 Security Group (Qihoo 360). AhnLab Endpoint PLUS is developed by AhnLab. Vendor maturity, funding stage, and team size can be important factors when evaluating long-term viability and support quality.

360 High-Risk Vulnerability Immunization Tool V2.0 and AhnLab Endpoint PLUS serve similar Endpoint Protection Platform use cases: both are Endpoint Protection Platform tools. Review the feature comparison above to determine which fits your requirements.